Skip to content
Home/Companies/HealthTech/Primo Group
PG

Primo Group

HealthTech·Italy·Exited 2024·Held 9yr

Primo Group is a consumer health company, headquartered in Italy.

Entry
2015
Hold
9yr
Exit
2024
Est. EV
–

Who owns Primo Group?

Primo Group was owned by ARCHIMED through MED I (2014 vintage) from 2015 to 2024, exited via Secondary.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

HQItaly
SectorConsumer Health
Exit Type
Secondary
Buyer
MOIC
Exit Year
2024

More from MED I

Other portfolio companies in the same fund.

Esperion Therapeutics
Active
Stago
Active
MedTechFrance· 2026
Fytexia
Exited 2023
HealthTechFrance· 2016
to
Micromed
Exited 2023
MedTechFrance· 2016
to
Natural Origins
Exited 2017
HealthTechFrance· 2016
to
Polyplus
Exited 2023
BiotechFrance· 2016
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings